SLC2A9 and hyperuricemia: Given the advancements in drug delivery systems and a deeper understanding of renal mechanisms and urate transporters, numerous novel therapeutic agents for managing hyperuricemia are currently in various stages of clinical development.372,415,416 Emerging pharmacological agents for hyperuricemia management are currently undergoing various stages of clinical development, ranging from preclinical to early clinical trials.